<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39516956</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2052-0492</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of intensive care</Title><ISOAbbreviation>J Intensive Care</ISOAbbreviation></Journal><ArticleTitle>Long-term health outcomes of COVID-19 in ICU- and non-ICU-treated patients up to 2&#xa0;years after hospitalization: a longitudinal cohort study (CO-FLOW).</ArticleTitle><Pagination><StartPage>47</StartPage><MedlinePgn>47</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">47</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40560-024-00748-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Many patients hospitalized for COVID-19 experience long-term health problems, but comprehensive longitudinal data up to 2&#xa0;years remain limited. We aimed to (1) assess 2-year trajectories of health outcomes, including comparison between intensive care unit (ICU) treated and non-ICU-treated patients, and (2) identify risk factors for prominent health problems post-hospitalization for COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The CO-FLOW multicenter prospective cohort study followed adults hospitalized for COVID-19 at 3, 6, 12, and 24&#xa0;months post-discharge. Measurements included patient-reported outcomes (a.o., recovery, symptoms, fatigue, mental health, sleep quality, return to work, health-related quality of life [HRQoL]), and objective cognitive and physical tests. Additionally, routine follow-up data were collected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">650 patients (median age 60.0 [IQR 53.0-67.0] years; 449/650 [69%] male) surviving hospitalization for COVID-19 were included, of whom 273/650 (42%) received ICU treatment. Overall, outcomes improved over time. Nonetheless, 73% (322/443) of patients had not completely recovered from COVID-19, with memory problems (274/443; 55%), concentration problems (259/443; 52%), and dyspnea (251/493; 51%) among most frequently reported symptoms at 2&#xa0;years. Moreover, 61% (259/427) had poor sleep quality, 51% (222/433) fatigue, 23% (102/438) cognitive failures, and 30% (65/216) did not fully return to work. Objective outcome measures showed generally good physical recovery. Most outcomes were comparable between ICU- and non-ICU-treated patients at 2&#xa0;years. However, ICU-treated patients tended to show slower recovery in neurocognitive symptoms, mental health outcomes, and resuming work than non-ICU-treated patients, while showing more improvements in physical outcomes. Particularly, female sex and/or pre-existing pulmonary disease were major risk factors for poorer outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">73% (322/443) of patients had not completely recovered from COVID-19 by 2&#xa0;years. Despite good physical recovery, long-term neurocognitive complaints, dyspnea, fatigue, and impaired sleep quality persisted. ICU-treated patients showed slower recovery in neurocognitive and mental health outcomes and resumption of work. Tailoring long-term COVID-19 aftercare to individual residual needs is essential. Follow-up is required to monitor further recovery.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">NL8710, registration date 12-06-2020.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Berentschot</LastName><ForeName>J C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0003-4640-9947</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands. j.berentschot@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bek</LastName><ForeName>L M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heijenbrok-Kal</LastName><ForeName>M H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rijndam Rehabilitation, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bommel</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribbers</LastName><ForeName>G M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rijndam Rehabilitation, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aerts</LastName><ForeName>J G J V</ForeName><Initials>JGJV</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hellemons</LastName><ForeName>M E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>van den Berg-Emons</LastName><ForeName>H J G</ForeName><Initials>HJG</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CO-FLOW collaboration Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>10430022010026</GrantID><Acronym>ZONMW_</Acronym><Agency>ZonMw</Agency><Country>Netherlands</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Intensive Care</MedlineTA><NlmUniqueID>101627304</NlmUniqueID><ISSNLinking>2052-0492</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long-term health outcomes</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests related to this paper.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Aerts</LastName><ForeName>Joachim G J V</ForeName><Initials>JGJV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bek</LastName><ForeName>L Martine</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berentschot</LastName><ForeName>Julia C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>van den Berg-Emons</LastName><ForeName>Rita J G</ForeName><Initials>RJG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bindraban</LastName><ForeName>Sieshem</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blox</LastName><ForeName>Wouter J B</ForeName><Initials>WJB</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Bommel</LastName><ForeName>Jasper</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gajadin</LastName><ForeName>Shai A</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Genderen</LastName><ForeName>Michel E</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gommers</LastName><ForeName>Diederik A M P J</ForeName><Initials>DAMPJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heijenbrok-Kal</LastName><ForeName>Majanka H</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hellemons</LastName><ForeName>Merel E</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heller</LastName><ForeName>Roxane</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ista</LastName><ForeName>Erwin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Loon-Kooij</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luijkx</LastName><ForeName>Chantal</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osterthun</LastName><ForeName>Rutger</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oswald</LastName><ForeName>Laurien</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ribbers</LastName><ForeName>Gerard M</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Rossem</LastName><ForeName>Ronald N</ForeName><Initials>RN</Initials></Investigator><Investigator ValidYN="Y"><LastName>van de Sande</LastName><ForeName>Herbert J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Stoep</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tazmi-Staal</LastName><ForeName>Janette J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wijffels</LastName><ForeName>Markus P J M</ForeName><Initials>MPJM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Willems</LastName><ForeName>Eva G</ForeName><Initials>EG</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>9</Day><Hour>0</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39516956</ArticleId><ArticleId IdType="pmc">PMC11546104</ArticleId><ArticleId IdType="doi">10.1186/s40560-024-00748-w</ArticleId><ArticleId IdType="pii">10.1186/s40560-024-00748-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. WHO Coronavirus (COVID-19) Dashboard. Updated 13 Sept 2023. Accessed 18 Sept 2023. https://covid19.who.int/.</Citation></Reference><Reference><Citation>Group P-CC. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Bek LM, Berentschot JC, Heijenbrok-Kal MH, et al. Symptoms persisting after hospitalisation for COVID-19: 12 months interim results of the CO-FLOW study. ERJ Open Res. 2022;8(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9421428</ArticleId><ArticleId IdType="pubmed">36284829</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;a systematic review and meta-analysis. J Med Virol. 2022;94(1):253&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tene L, Bergroth T, Eisenberg A, David SSB, Chodick G. Risk factors, health outcomes, healthcare services utilization, and direct medical costs of patients with long COVID. Int J Infect Dis. 2023;128:3&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">36529373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Cancela-Cilleruelo I, Moro-L&#xf3;pez-Menchero P, Rodr&#xed;guez-Jim&#xe9;nez J, Pellicer-Valero OJ. Exploring the trajectory recovery curve of the number of post-COVID symptoms: the LONG-COVID-EXP-CM Multicenter Study. Int J Infect Dis. 2022;117:201&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8826603</ArticleId><ArticleId IdType="pubmed">35150911</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Diseases. 2021;74(7):1191&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Hou C, Shen Y, et al. Two-year health outcomes in hospitalized COVID-19 survivors in China. JAMA Netw Open. 2022;5(9):e2231790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9478774</ArticleId><ArticleId IdType="pubmed">36107425</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Q, Joyce EE, Ebrahimi OV, et al. COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark. Lancet Reg Health Eur. 2023;35: 100756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10730314</ArticleId><ArticleId IdType="pubmed">38115966</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, Menges D, Anagnostopoulos A, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381:e074425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders&#x2019; conference*. Crit Care Med. 2012;40(2):502&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlgren C, Forsberg G, Divanoglou A, et al. Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study. Lancet Reg Health Eur. 2023;28: 100595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9951394</ArticleId><ArticleId IdType="pubmed">36855599</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlake JH, Wesselius S, van Genderen ME, van Bommel J, Boxma-de Klerk B, Wils EJ. Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: a single-center, observational study. PLoS ONE. 2021;16(8): e0255774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357130</ArticleId><ArticleId IdType="pubmed">34379644</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirican E, Bal T. COVID-19 disease severity to predict persistent symptoms: a systematic review and meta-analysis. Prim Health Care Res Dev. 2022;23: e69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9706304</ArticleId><ArticleId IdType="pubmed">36352492</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Musheyev B, Boparai MS, Kimura R, et al. Longitudinal medical subspecialty follow-up of critically and non-critically ill hospitalized COVID-19 survivors up to 24 months after discharge. Intern Emerg Med. 2023;18(2):477&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9887251</ArticleId><ArticleId IdType="pubmed">36719540</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. COVID-19 op de Nederlandse verpleegafdelingen; Pati&#xeb;ntkarakteristieken en uitkomsten. Updated 30 Mar 2023. Accessed 1 May 2024. https://stichting-nice.nl/.</Citation></Reference><Reference><Citation>Bek LM, Berentschot JC, Hellemons ME, et al. CO-FLOW: COvid-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: study protocol of a multicenter prospective cohort study following patients 2 years after hospital discharge. BMC Health Serv Res. 2021;21(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8379596</ArticleId><ArticleId IdType="pubmed">34419032</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimby G, B&#xf6;rjesson M, Jonsdottir IH, Schnohr P, Thelle DS, Saltin B. The, &#x201c;Saltin-Grimby Physical Activity Level Scale&#x201d; and its application to health research. Scand J Med Sci Sports. 2015;25(Suppl 4):119&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">26589125</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A, Baumgart A, Evangelidis N, et al. Core outcome measures for trials in people with coronavirus disease 2019: respiratory failure, multiorgan failure, shortness of breath, and recovery. Crit Care Med. 2021;49(3):503&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892260</ArticleId><ArticleId IdType="pubmed">33400475</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kleijn WP, De Vries J, Wijnen PA, Drent M. Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis. Respir Med. 2011;105(9):1388&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">21700440</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams N. The MRC breathlessness scale. Occup Med (Lond). 2017;67(6):496&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28898975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. Significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ. 1959;2(5147):257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1990153</ArticleId><ArticleId IdType="pubmed">13823475</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann C. International experiences with the Hospital Anxiety and Depression Scale&#x2014;a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">9055211</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss DS, Marmar CR, Wilson JP, Keane TM. Assessing psychological trauma and PTSD. In: The Impact of Events Scale&#x2014;Revised. 1997;19:399&#x2013;411.</Citation></Reference><Reference><Citation>Zilberg NJ, Weiss DS, Horowitz MJ. Impact of Event Scale: a cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes. J Consult Clin Psychol. 1982;50(3):407&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">7096742</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">7126941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponds R, Boxtel M, Jolles J. De &#x201c;Cognitive Failure Questionnaire&#x201d; als maat voor subjectief cognitief functioneren. Tijdschrift voor Neuropsychologie. 2006;1:37&#x2013;45.</Citation></Reference><Reference><Citation>Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>Merellano-Navarro E, Collado-Mateo D, Garc&#xed;a-Rubio J, Gusi N, Olivares PR. Validity of the International Fitness Scale &#x201c;IFIS&#x201d; in older adults. Exp Gerontol. 2017;95:77&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">28476584</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandelanotte C, Bourdeaudhuij I, Philippaerts R, Sjostrom M, Sallis JF. Reliability and validity of a computerized and dutch version of the international physical activity questionnaire (IPAQ). J Phys Act Health. 2005;2:63&#x2013;75.</Citation></Reference><Reference><Citation>Post MW, van der Zee CH, Hennink J, Schafrat CG, Visser-Meily JM, van Berlekom SB. Validity of the Utrecht scale for evaluation of rehabilitation&#x2013;participation. Disabil Rehabil. 2012;34(6):478&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">21978031</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Hakkaart-van RL. The iMTA Productivity Cost Questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Health. 2015;18(6):753&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26409601</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroQol G. EuroQol&#x2014;a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">9817123</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xe9;dirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Laboratories ATSCoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Koufaki P, Mercer TH, Naish PF. Effects of exercise training on aerobic and functional capacity of end-stage renal disease patients. Clin Physiol Funct Imaging. 2002;22(2):115&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">12005153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohannon RW. Muscle strength: clinical and prognostic value of hand-grip dynamometry. Curr Opin Clin Nutr Metab Care. 2015;18(5):465&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">26147527</ArticleId></ArticleIdList></Reference><Reference><Citation>de Morton NA, Davidson M, Keating JL. The de Morton Mobility Index (DEMMI): an essential health index for an ageing world. Health Qual Life Outcomes. 2008;6:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2551589</ArticleId><ArticleId IdType="pubmed">18713451</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommers J, Vredeveld T, Lindeboom R, Nollet F, Engelbert RHH, van der Schaaf M. de Morton Mobility Index is feasible, reliable, and valid in patients with critical illness. Phys Ther. 2016;96(10):1658&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">27081202</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5):1384&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9817683</ArticleId></ArticleIdList></Reference><Reference><Citation>Strassmann A, Steurer-Stey C, Dalla Lana K, et al. Population-based reference values for the 1-min sit-to-stand test. Int J Public Health. 2013;58(6):949&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">23974352</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodds RM, Syddall HE, Cooper R, et al. Grip strength across the life course: normative data from twelve British studies. PLoS ONE. 2014;9(12): e113637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4256164</ArticleId><ArticleId IdType="pubmed">25474696</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Brusasco V, Burgos F, et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016.</Citation><ArticleIdList><ArticleId IdType="pubmed">28049168</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S, Graham BL, Cooper BG, et al. Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50(3):1700010.</Citation><ArticleIdList><ArticleId IdType="pubmed">28893868</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3&#x2013;95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Berentschot JC, Heijenbrok-Kal MH, Bek LM, et al. Physical recovery across care pathways up to 12 months after hospitalization for COVID-19: a multicenter prospective cohort study (CO-FLOW). Lancet Reg Health Eur. 2022;22: 100485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9402257</ArticleId><ArticleId IdType="pubmed">36039177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bek LM, Hellemons ME, Berentschot JC, et al. Cognitive and psychological recovery patterns across different care pathways 12 months after hospitalization for COVID-19: a multicenter cohort study (CO-FLOW). Ann Phys Rehabil Med. 2023;66(5): 101737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9915122</ArticleId><ArticleId IdType="pubmed">37043952</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesakkers H, van der Hoeven JG, van den Boogaard M, Zegers M, Group M-Ir. Two-year physical, mental and cognitive outcomes among intensive care unit survivors treated for COVID-19. Intensive Care Med. 2023;49(5):597&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10073777</ArticleId><ArticleId IdType="pubmed">37017696</ArticleId></ArticleIdList></Reference><Reference><Citation>van Veenendaal N, van der Meulen IC, Onrust M, Paans W, Dieperink W, van der Voort PHJ. Six-month outcomes in COVID-19 ICU patients and their family members: a prospective cohort study. Healthcare (Basel). 2021;9(7):865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8305246</ArticleId><ArticleId IdType="pubmed">34356243</ArticleId></ArticleIdList></Reference><Reference><Citation>Bek LM, Berentschot JC, Hellemons ME, et al. Return to work and health-related quality of life up to 1&#xa0;year in patients hospitalized for COVID-19: the CO-FLOW study. BMC Med. 2023;21(1):380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10546751</ArticleId><ArticleId IdType="pubmed">37784149</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Brown LM, Fineberg HV, National Academies of Sciences E, Medicine Committee on Examining the Working Definition for Long C. Long Covid Defined. N Engl J Med. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">39083764</ArticleId></ArticleIdList></Reference><Reference><Citation>Norredam M, Hayward S, Deal A, Agyemang C, Hargreaves S. Understanding and addressing long-COVID among migrants and ethnic minorities in Europe. Lancet Reg Health Eur. 2022;19: 100427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9241826</ArticleId><ArticleId IdType="pubmed">35789882</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C, Stewart ID, Plekhanova T, et al. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2023;11(8):673&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10156429</ArticleId><ArticleId IdType="pubmed">37072018</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhou Y, Ma J, et al. The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal Transduct Target Ther. 2023;8(1):416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10618229</ArticleId><ArticleId IdType="pubmed">37907497</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe0; M, Mercad&#xe9;-Besora N, Kolde R, et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med. 2024;12(3):225&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>